Syngene International

Nifty Pharma index nearly doubles since March; 3 pharma stocks set to rally up to 45% 

Macquaries sees Divi's Laboratories and Syngene International as well placed in terms of growth, margin profile and return ratios

Sensex, nifty,

Syngene delivers sustained growth in Q4 FY16

Revenue grows 31 per cent to Rs 334 crore; EBITA up by 23 per cent to Rs 106 crore

Rallis India, NHPC, Bharti Infratel among 11 stocks that remained in focus today

Raymond stocks closed 5.07 per cent up at Rs 418.80 after it reported over twofold jump in consolidated net profit at Rs 56.22 crore for the fourth quarter ended March 31, on account of revenue growth and profitability from l

stocks in focus today

Biocon shares fall post Q3 results, Syngene International gains over 7%

Biocon's contract research arm Syngene International on Thursday reported 31.25 per cent rise in net profit to Rs 58.8 crore for the third quarter of 2015-16 financial year.

bse sensex, nse nifty, stocks to bet on

Syngene appoints Jonathan Hunt as CEO-designate

Hunt will be responsible for strengthening Syngene’s relations with its existing global customers

Alone and loving it: Lal Pathlabs and five other stock singles

After the success of Dr Lal Pathlabs, we take a look at some companies which are the only listed ones in their category.

Stocks in focus today

Syngene to spend $100 m on new plant at Mangalore SEZ

Syngene International, a contract research arm of biotech major Biocon, has firmed up plans to diversify into contract manufacturing.

Syngene International IPO oversubscribed 31 times

The IPO is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene Syngene International’s (Syngene) Initial Public Offering (IPO) has been oversubscribed 31 times based on the electronic bid file ava

Syngene International gets FIPB approval

Foreign investment limit raised to 44 per cent

Income Tax Calculator, Budget 2019, How to Calculate Income Tax


Stock Market

Most Read


Top News


Related Articles